The problem was the decision to undergo treatment when the complications outweighed the benefit. What if we did more screening but also less treatment?
Even if we perform zero treatment, this data argument should be sufficient reason to increase rather than decrease the number of MRIs we do. CT is different since there is some radiation exposure risk that must be considered.
If you do disclose the results and proceed with a normal patient relationship, you are in the same dilemma as above. You don't know if the tumor is dangerous or not, so the safe course is to do a biopsy, which is itself often invasive. Depending on the results that may lead larger surgeries to exicse large parts of organs and/or the starting of chemotherapy.
Also MRIs are expensive, and in the U.S. a significant amount of that cost (usually hundreds of dollars) is borne by the patient, even if they are insured.
But I don't think we lack for MRI or CT data, there are lots ordered every year. The biggest problem with gathering your data set would be medical privacy regulations. I would guess that medical researchers have already tried longitudinal studies on this to see if different imaging characteristics lead to different outcomes. It's a hard problem, the only data you really get from scans is tissue density, which can probably never tell you what you need to know.